VANECK PHARMACEUTICAL ETF - USD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 90.46 USD | +1.48% |
|
+0.33% | +11.18% |
Investment objective
VanEck Vectors® Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.
| Name |
Price
|
Change
|
5d. change
|
1st Jan change
|
Weight
| |
|---|---|---|---|---|---|---|
| 820.3 USD | +0.65% | +1.60% | +40.73% | 9.76% | ||
| 146.9 USD | +1.09% | -0.07% | -6.30% | 6.36% | ||
| 125.5 USD | +0.81% | -3.05% | +15.15% | 5.84% | ||
| 161.2 USD | +3.15% | +2.66% | +4.05% | 5.46% | ||
| 226.6 USD | +2.74% | +3.51% | +10.32% | 4.82% | ||
| 569.6 USD | +1.54% | +1.58% | +23.03% | 4.48% | ||
More news
In partnership with
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-31 | 90.46 | +1.48% | 309,472 |
| 24-05-30 | 89.14 | +0.51% | 71,064 |
| 24-05-29 | 88.69 | -0.21% | 242,913 |
| 24-05-28 | 88.88 | -1.10% | 142,081 |
| 24-05-24 | 89.87 | -0.32% | 53,165 |
Other stock markets
Delayed Quote Nasdaq
Last update May 31, 2024 at 04:00 pm EDT
More quotesETF Ratings
 |
Description
| US92189F6925 | |
|---|---|
| Total Expense Ratio | 0.35% |
| Asset Class | |
| Sector | |
| Size | |
| Currency | |
| Provider | |
| Underlying | MVIS US Listed Pharmaceutical 25 Net Total Return Index - USD |
Features and characteristics
| Jurisdiction | |
| Fund Structure | |
| Replication Method | |
| Replication Model | |
| Date of creation |
2011-12-18
|
| Dividend Policy | |
| Geographical Focus |
AuM evolution ( 2024-04-29 )
| AuM (EUR) | 500 M€ |
|---|---|
| AuM 1M | 510 M€ |
| AuM 3 months | 409 M€ |
| AuM 6 months | 362 M€ |
| AuM 12 months | 364 M€ |
- Stock Market
- ETF
- PPH ETF
